Recombinant Human CPN1 Protein, Glycoengineered Human Cell Lines

Recombinant Human CPN1 protein (NP_001299.1) is produced in Glycoengineered Human Cell Lines. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications.

Glycoengineered Human Cell Lines

Human

His-tag, FC-tag

>90%, determined by SDS-PAGE.

Regular batch

None

CPN1

Carboxypeptidase N catalytic chain

Carboxypeptidase N is a plasma metallo-protease that cleaves basic amino acids from the C terminal of peptides and proteins. The enzyme is important in the regulation of peptides like kinins and anaphylatoxins, and has also been known as kininase-1 and anaphylatoxin inactivator. This enzyme is a tetramer comprised of two identical regulatory subunits and two identical catalytic subunits; this gene encodes the catalytic subunit. Mutations in this gene can be associated with angioedema or chronic urticaria resulting from carboxypeptidase N deficiency.

Carboxypeptidase N, Polypeptide 1; Arginine Carboxypeptidase; Anaphylatoxin Inactivator; Lysine Carboxypeptidase; Carboxypeptidase N Small Subunit; Plasma Carboxypeptidase B; Serum Carboxypeptidase N; Carboxypeptidase K; EC 3.4.17.3; Kininase I; Kininase-1; SCPN; CPN; Carboxypeptidase N, Polypeptide 1, 50kD; Carboxypeptidase N Polypeptide 1 50 KD; Carboxypeptidase N Catalytic Subunit; Carboxypeptidase N Polypeptide 1; EC 3.4.17; ACBP